NIFTY 50

USD/INR

Gold

NIFTY 100 
Largecap

NIFTY 100 
Midcap

NIFTY 100 
Smallcap

NIFTY 
Bank

NIFTY 
IT

NIFTY 
Pharma

NIFTY 
Next 50

NIFTY 
Largemidcap 250

NIFTY 500

NIFTY 
Midsmallcap 400

NIFTY FMCG

NIFTY PSU Bank

NIFTY Realty

NIFTY Auto

NIFTY 
Financial Services

NIFTY Media

NIFTY Metal

NIFTY 
Private Bank

NIFTY 
Healthcare

Mazagon Dock Shipbuilders Ltd

Power Grid Corporation of India Ltd

Lupin Ltd

Sun Pharmaceutical Industries Ltd

UltraTech Cement Ltd

Motilal Oswal Large Cap Fund

DSP Top 100 Equity Fund

WOC Large Cap Fund

Canara Rob Bluechip Equity Fund

Mirae Asset Large Cap Fund

Insured Upto 5L

Suryoday SF Bank

North East SF Bank

Utkarsh SF Bank

Equity & Gold Asset Allocation

Timeless Asset Allocation

Horizon 2035 Target Date

Top 100 Stocks - Quant Tracker

The Naked Trader Model

TVS Apache sells over 6 million units over last 20 years

TVS Motor Company (TVSM) is celebrating two significant milestones for its premium motorcycle brand, TVS Apache - the brand's 20th anniversary and the trust it has garnered of over 6 million customers worldwide. Engineered with cutting-edge racing technology and inspired by TVS Racing's championship pedigree, TVS Apache has become one of the fastest-growing sports motorcycle brands across 60+ countries. For two decades, it has fuelled the adrenaline of the youth and of motorcycle enthusiasts, delivering the ultimate combination of power, precision and performance on the streets and the track. Expressing his gratitude on these milestones, Sudarshan Venu, Managing Director, TVS Motor Company said, We are immensely grateful to the 6 million+ passionate riders of TVS Apache for their unwavering trust and enthusiasm over the last 20 years. Their love for performance and adrenaline has propelled TVS Apache to become one of the fastest-growing sports motorcycle brands globally. This milestone belongs to every member of the TVSM family - our engineers, designers, factory teams, dealers, suppliers, and partners - who push the limits of innovation every day. TVS Apache's enduring success emanates from cutting-edge racing technology, precision engineering, and unmatched performance. It is a testament to our relentless commitment to empowering the new generation of young riders who live and breathe the thrill of motorcycling.'Powered by Capital Market - Live

Bonus

Cash Dividend

Bank Loan Growth

Sensex slumps 332 pts; Nifty ends near 23,250; IT shares decline

The headline equity benchmarks ended with moderate losses today, following a global market sell-off triggered by US President Donald Trump's announcement of reciprocal tariffs. The Nifty ended near the 23,250 mark. Pharma, PSU bank, and consumer durable shares advanced while IT, auto and oil & gas shares tumbled. As per the provisional closing, the barometer index, the S&P BSE Sensex, tumbled 322.08 points or 0.42% to 76,295.36. The Nifty 50 index shed 82.25 points or 0.35% to 23,250.10. In the broader market, the S&P BSE Mid-Cap index rose 0.31% and the S&P BSE Small-Cap index added 0.76%. The market breadth was strong. On the BSE, 2,808 shares rose and 1,176 shares fell. A total of 139 shares were unchanged. The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, shed 0.89% to 13.60. Trump's Tariff Shock: US President Donald Trump has announced a sweeping set of reciprocal tariffs, aiming to counter what he calls unfair trade practices. A 10% baseline tariff will be imposed on all imports starting April 5, impacting the United Kingdom, Singapore, Brazil, Australia, New Zealand, Turkey, Colombia, Argentina, El Salvador, United Arab Emirates, and Saudi Arabia. However, around 60 countries deemed worst offenders - those that impose higher tariffs on US goods or create trade barriers'will face significantly steeper tariffs beginning April 9. These include China (54%), the European Union (20%), Vietnam (46%), Thailand (36%), Japan (24%), Cambodia (49%), South Africa (30%), and Taiwan (32%). While Canada and Mexico are exempt from these new tariffs, they remain subject to previous trade measures tied to border security and fentanyl-related concerns. Additionally, Trump has also announced a 25% tariff on all foreign-made automobiles, set to take effect at midnight on April 3. Importantly, no new reciprocal tariffs were announced for the pharmaceutical sector. According to a White House fact sheet, drugs and certain other products'some of which are already subject to existing tariffs'will not be affected by the latest levies. However, Trump has hinted that future tariffs on pharmaceuticals, semiconductors, and other sectors may be unveiled at a later date. Buzzing Index: The Nifty IT index tumbled 4.21% to 34,757.25. The index added 0.84% in the previous trading sessions. Persistent Systems (down 9.84%), Coforge (down 7.78%), Mphasis (down 4.09%), Tata Consultancy Services (down 3.98%) and Tech Mahindra (down 3.79%), HCL Technologies (down 3.78%), Infosys (down 3.49%), LTIMindtree (down 3.44%), Wipro (down 2.77%) and Oracle Financial Services Software (down 2.63%) declined. Stocks in Spotlight: Hero MotoCorp fell 0.74%. The world's largest manufacturer of motorcycles and scooters has reported 12% increase in total two-wheeler sales to 549,604 units in March 2025 from 490,415 units sold in March 2024. Marico rose 0.53%. The company said that during the quarter, it expects gradual improvement in overall consumption sentiment on the back of moderating retail and food inflation as well as forecasts of a normal monsoon. AU Small Finance Bank (SFB) jumped 4.58% after the bank's total deposits climbed 10.7% to Rs 1,24,270 crore as of 31st March 2025 as compared with Rs 1,12,260 crore as of 31st December 2024. Bharat Electronics (BEL) added 1.84% after the company has signed a contract with Indian Air Force (IAF) valued at Rs 593.22 crore. ESAF Small Finance Bank (SFB) rallied 5.44% after the bank announced that its total deposits jumped 17.16% to Rs 23,277 crore as of 31st March 2025 as compared with Rs 19,868 crore as of 31st March 2024. IDFC First Bank advanced 5.49% after the bank's total business (loans & advances and customer deposits) jumped 22.72% from Rs 4,84,394 crore as of 31 March 2025 to Rs 3,94,718 crore as of 31 March 2024. Gland Pharma rallied 1.30% after the company received approval from the United States Food and Drug Administration (USFDA) for Acetaminophen Injection, 10 mg/mL (500 mg/50 mL and mg/100 mL) bags. GE Power India rallied 3.14% after the company secured a purchase order worth Rs 38.2 crore from state-owned NTPC for the supply of generator parts. Shakti Pumps India advanced 3.05% after the company announced that it has received a Letter of Award (LoA) worth Rs 12.42 crore from the Maharashtra Energy Department Agency (MEDA). Shilpa Medicare rose 4.03% after the company announced that its marketing partner, Amneal Pharmaceuticals, has launched BORUZU injections. BORUZU (Bortezomib for injection 3.5mg/1.4ml) is a proteasome inhibitor used for the treatment of multiple myeloma and mantle cell lymphoma. It serves as a reference to the branded product Velcade, which is a lyophilized powder that requires reconstitution before use. Hariom Pipe Industries surged 6.83% after the company reported 46% jump in sale of value-added products (VAP) to 72,149 MT in Q4 FY25 from 49,260 MT in Q4 FY24. Global Markets: US Dow Jones index futures plummeted 1,098 points, signaling a weak opening for Wall Street as markets reacted to President Donald Trump's latest trade offensive. Trump announced a sweeping 10% tariff on all imported goods, with even steeper reciprocal duties for certain nations. European shares traded lower while Asian markets plunged after U.S. President Donald Trump imposed hefty reciprocal tariffs on over 180 countries and territories - several of which are in the region. In a bold move, Trump unveiled new trade measures on Wednesday, slapping a 24% reciprocal tariff on Japan, despite its status as one of the United States' closest allies. China faces an additional 34% tariff, adding to the existing 20% levies. Meanwhile, the European Union and others will see tariffs ranging from 20% to 49%. The broad-based tariffs take effect on April 5, while the country-specific hikes begin on April 9. Notably, Canada and Mexico were exempt from the baseline tariffs due to existing agreements, but they will still be subject to 25% duties on most goods. Additionally, the White House announced a 25% tariff on foreign-made automobiles and key auto parts, set to take effect on April 3, 2025. Trump defended the move, citing unfair trade practices and currency manipulation, arguing that the tariffs would revitalize American industries and reduce national debt. Financial markets responded swiftly, with US stock futures plunging on fears of rising inflation and retaliatory measures from key trading partners. Asian markets also slid as investors scrambled for safe-haven assets, worried that Trump's aggressive trade stance could dent global growth. Before the tariff announcement, US stocks had a volatile session, with major indices posting gains. The S&P 500 rose 0.7%. The Dow Jones Industrial Average added 0.6%, and the Nasdaq composite climbed 0.9%. Tesla rebounded, surging over 5%, following reports that CEO Elon Musk may step down from his government advisory role to fully focus on the EV company. Rivian Automotive slumped 6% after reporting a sharp decline in Q1 deliveries, as demand softens. Ncino plunged 20% after issuing disappointing guidance, missing Wall Street estimates. CoreWeave Inc extended its rally, soaring 16%, amid reports that Google is in advanced talks to rent Nvidia AI services from the cloud computing firm. On the macroeconomic front, the US ADP National Employment Report showed that private payrolls increased by 155,000 in March, following an upwardly revised 84,000 gain in February'a sign that the labor market remains resilient despite economic uncertainties. Powered by Capital Market - Live

Ashish Kacholia recent bets

Morgan Stanley recent bets

Recent Big Buys

Top deal-making stocks

Most insider traded stocks

Leading investors

Kirloskar Oil rallies on securing Rs 270-cr defence order from Indian Navy

According to an exchange filing, the order pertains to the design and development of a 6 MW medium-speed marine diesel engine under the Make-I scheme. The project sanction order was signed on 2 April 2025, marking a significant milestone in India's efforts to enhance indigenous defense capabilities. The order includes the design of a medium-speed marine diesel engine scalable from 3-10 MW capacity, along with the development and supply of a prototype 6 MW engine. The prototype will feature an indigenous content of over 50% and is being developed with an estimated cost of Rs 270 crore, with 70% funding provided by the Government of India under the Make-I scheme. Under this project, the company will design and develop in-house medium-speed engines scalable from 3 MW to 10 MW, and the developed engines will be used for main propulsion and power generation on ships of the Indian Navy and Indian Coast Guard. Currently, most of these engines are imported, and this project is a significant step in the Government of India's vision of indigenisation and achieving self-reliance in marine engine development in this country. This marks a significant step in the ongoing efforts of the Government of India to indigenise critical technologies and achieve Aatmanirbharta in Defence. The project is scheduled for completion within 36 months. The company also clarified that the contract does not involve any related party transactions and confirmed that neither the promoter, promoter group, nor any group companies have any interest in the awarding entity. Gauri Kirloskar, managing director of Kirloskar Oil Engines, said, 'We are honoured to be selected by the Indian Navy for this prestigious project and to have the opportunity to contribute to the building of our nation. This is a proud moment for all of us at KOEL, and I am sure that with the technical and R&D strength that we have, we will be able to deliver yet another world-class product to the Indian Navy. We would like to thank the Ministry of Defence and the Indian Navy, for their support and guidance.' The official announcement was made on Wednesday, 02 April 2025, after market hours. Kirloskar Oil Engines is a leader in the manufacturing of diesel engines, agricultural equipment and generator sets with a sizable presence in international markets. The company's consolidated net profit fell 20.6% to Rs 71.30 crore in Q3 FY25 as against Rs 89.82 crore posted in Q3 FY24. However, revenue from operations rose 4.5% YoY to Rs 1,453.70 crore in the quarter ended 31 December. Powered by Capital Market - Live

Volumes spurt at Aurobindo Pharma Ltd counter

K P R Mill Ltd, Gland Pharma Ltd, Cipla Ltd, Lupin Ltd are among the other stocks to see a surge in volumes on BSE today, 03 April 2025.Aurobindo Pharma Ltd registered volume of 1.89 lakh shares by 10:47 IST on BSE, a 8.81 fold spurt over two-week average daily volume of 21456 shares. The stock rose 2.07% to Rs.1,182.60. Volumes stood at 16577 shares in the last session.K P R Mill Ltd clocked volume of 47258 shares by 10:47 IST on BSE, a 5.95 times surge over two-week average daily volume of 7947 shares. The stock gained 7.03% to Rs.1,028.10. Volumes stood at 30349 shares in the last session.Gland Pharma Ltd saw volume of 59207 shares by 10:47 IST on BSE, a 5.93 fold spurt over two-week average daily volume of 9986 shares. The stock increased 3.40% to Rs.1,587.35. Volumes stood at 3058 shares in the last session.Cipla Ltd recorded volume of 90152 shares by 10:47 IST on BSE, a 3.96 times surge over two-week average daily volume of 22780 shares. The stock gained 2.91% to Rs.1,495.00. Volumes stood at 15171 shares in the last session.Lupin Ltd clocked volume of 64384 shares by 10:47 IST on BSE, a 3.67 times surge over two-week average daily volume of 17527 shares. The stock gained 3.61% to Rs.2,082.00. Volumes stood at 22646 shares in the last session.Powered by Capital Market - Live

Hero MotoCorp posts 12% YoY increase in March'25 auto sales; FY25 sales at 5.9 million units

While the company's domestic sales rose by 11% YoY to 510,086 units, exports grew by 27% YoY to 39,518 units during the period under review. The company's motorcycle sales and scooter sales for March 2025 were 506,641 units (up 11% YoY) and 42,963 units (up 28% YoY), respectively. VIDA, which is Hero's electric mobility brand, also saw strong momentum in March 2025. It has dispatched 7,787 units of its electric scooter ' VIDA V2 ' during the period under review, reflecting positive market response. Hero MotoCorp has registered sales of 5,899,187 units in FY25, which is higher by 5% as compared with the figure of 5,621,455 units for FY24. The company sold 5,611,758 units in FY25 in India, achieving growth of 4% over FY24. Hero continued its strong momentum in global markets, reaching 287,429 units in FY25 - a robust 43% increase from 200,923 units sold in the previous fiscal year. Between April 2024 and March 2025, VIDA managed to sustained its growth trajectory as it dispatched over 58,000 electric scooters. To enhance customer experience and offer a hassle-free riding experience, the company has established an expansive VIDA fast charging network with over 3,600 charging points across 250+ cities in India and it also has an extensive network of over 500 service stations. The company sold more than 11,000 units of the Harley Davidson X440 during FY25, maintaining its position in the premium motorcycle segment. To make its premium portfolio more accessible, Hero MotoCorp established over 80 Premia dealerships across the country till date. These outlets feature dedicated sections for Hero, VIDA, and Harley-Davidson products. The company expanded its Hero 2.0 network to 930 outlets. Following the launch of the new Destini 125 scooter, the company commenced the dispatches of the Xoom 125 scooter during March 2025. It also commenced bookings for Xpulse 210 and Xtreme 250R premium motorcycles. In March 2025, Hero MotoCorp announced it will make a strategic investment into the electric three-wheeler category by acquiring a significant stake in Euler Motors. The company's board has approved a strategic investment of up to Rs 525 crore, in Euler Motors. Hero MotoCorp is engaged in the manufacturing and selling of motorised two-wheelers, spare parts and related services. The Company is a leading two wheeler manufacturer and has a dominant presence in domestic market. The company had reported 12.1% increase in standalone net profit to Rs 1,202.84 crore in Q3 FY25 as compared with Rs 1,073.38 crore in Q3 FY24. Revenue from operations rose 5% to Rs 10,210.78 crore in Q3 FY25. Powered by Capital Market - Live

ESAF SFB jumps after total deposits climb 17% YoY in Q4

On a sequential basis, the bank's total deposits increased 3.85% from Rs 22,415 crore as of 31st December 2024. Gross advances rose 3.74% to Rs 18,975 crore as of 31st March 2025 as compared with Rs 18,772 crore recorded on 31st March 2024. On quarter on quarter (QoQ) basis, the gross advances declined from Rs 18,291 crore as of 31st December 2024. Secured advance jumped 66.28% to Rs 9,799 crore as of 31st March 2025. Secured advance includes gold loan, mortgage, mobility, MSME and agriculture. Secured advances constitutes 51.64% of the gross advances as of 31st March 2025 as against 31.39% as of 31st March 2024. CASA stood at Rs 5,784 crore as of 31st March 2025 (up 28.48% YoY and up 3.43% QoQ). CASA ratio improved to 24.85% as of 31st March 2025 from 22.66% as of 31st March 2024. As of 31st March 2025, the bank's distribution network comprised 787 branches, 693 ATMs and 1,106 customer service centres spanning across 24 states and 2 union territories. ESAF Small Finance Bank primarily focus on expanding the banking horizon to new unbanked and underbanked area, yet bank stand with for all with presence in urban, semi urban, rural and rural unbanked areas. The bank reported a standalone net loss of Rs 210.90 crore in Q3 FY25 as compared with a net profit of Rs 112.14 crore in Q3 FY24. Total income fell 3% YoY to Rs 1,061.78 crore in Q3 FY25.Powered by Capital Market - Live

Indices trade with minor losses; IT shares decline

The headline equity benchmarks traded with minor losses in the morning trade. The downturn comes after US President Donald Trump announced wide-ranging tariffs on imports from partner and adversary nations alike, spurring fears of a recession in the US and trade wars worldwide. The Nifty traded near the 23,300 level. IT shares declined after advancing for the previous trading session. At 10:30 ST, the barometer index, the S&P BSE Sensex, slipped 136.17 points or 0.19% to 76,472.28. The Nifty 50 index fell 32.55 points or 0.14% to 23,302.60. In the broader market, the S&P BSE Mid-Cap index shed 0.09% and the S&P BSE Small-Cap index added 0.35%. The market breadth was positive. On the BSE, 2,290 shares rose and 1,206 shares fell. A total of 181 shares were unchanged. Trump's Tariff Shock: US President Donald Trump has announced a sweeping set of reciprocal tariffs, aiming to counter what he calls unfair trade practices. A 10% baseline tariff will be imposed on all imports starting April 5, impacting the United Kingdom, Singapore, Brazil, Australia, New Zealand, Turkey, Colombia, Argentina, El Salvador, United Arab Emirates, and Saudi Arabia. However, around 60 countries deemed worst offenders - those that impose higher tariffs on US goods or create trade barriers'will face significantly steeper tariffs beginning April 9. These include China (54%), the European Union (20%), Vietnam (46%), Thailand (36%), Japan (24%), Cambodia (49%), South Africa (30%), and Taiwan (32%). While Canada and Mexico are exempt from these new tariffs, they remain subject to previous trade measures tied to border security and fentanyl-related concerns. Additionally, Trump has also announced a 25% tariff on all foreign-made automobiles, set to take effect at midnight on April 3. Importantly, no new reciprocal tariffs were announced for the pharmaceutical sector. According to a White House fact sheet, drugs and certain other products'some of which are already subject to existing tariffs'will not be affected by the latest levies. However, Trump has hinted that future tariffs on pharmaceuticals, semiconductors, and other sectors may be unveiled at a later date. Buzzing Index: The Nifty IT index fell 3.20% to 35,123.40. The index added 0.84% in the previous trading sessions. Persistent Systems (down 8.32%), Coforge (down 5.69%), Mphasis (down 4.19%), Tata Consultancy Services (down 3.02%) and Tech Mahindra (down 2.94%), HCL Technologies (down 2.79%), Oracle Financial Services Software (down 2.75%), Infosys (down 2.48%), Wipro (down 1.92%) and LTIMindtree (down 1.75%) declined. Stocks in Spotlight: B R Goyal Infrastructure advanced 1.79% after the company received a work order worth Rs 10.90 crore from NHIT Eastern Projects for the improvement works in respect of Lakhnadon - Khawasa section of NH-44 in Madhya Pradesh. Lemon Tree Hotels rose 1.10% after the company announced that it has signed a license agreement viz. Lemon Tree Hotel, Jaipur, Rajasthan. Bajaj Auto fell 2.39%. The company has recorded total sales of 3,69,823 units in March 2025, which is higher by 1% as compared with the sales volume of 3,65,904 units sold in March 2024. Sky Gold and Diamonds shed 0.25%. The company said that its board has approved to establish a wholly owned subsidiary (WOS) in Dubai (UAE), positioning itself for significant export growth. Powered by Capital Market - Live

South Indian Bank Q4 gross advances grow 10% YoY

The bank's gross advances grew by 1.7% from Rs 86,966 crore as of 31 December 2024. The bank's total deposits stood at Rs 1,07,526 crore as of 31 March 2025, recording a growth of 5.50% year on year (YoY) and 2.03% quarter on quarter (QoQ). CASA stood at Rs 33,730 crore as of 31 March 2025, up 3.17% YoY and rose 2.74% QoQ. The CASA ratio declined to 31.37% in the fourth quarter of FY25 as against 32.08% posted in Q4 FY24 and 32.08% in Q3 FY25. South Indian Bank provides retail and corporate banking and para-banking activities such as debit cards and third-party product distribution, in addition to treasury and foreign exchange business. The bank's standalone net profit advanced 12% to Rs 341.87 crore in Q3 FY25 as against Rs 305.36 crore recorded in Q3 FY24. Total income grew by 6.9% year on year to Rs 2,817.96 crore during the quarter. Shares of South Indian Bank rose 0.51% to Rs 23.80 on the BSE.Powered by Capital Market - Live

Interarch Building gains on bagging Rs 300-cr LoI from new customer

The company informed that due to a commercial issue, it has not disclosed the name of the customer. The order encompasses the design, engineering, manufacturing, supply, and erection of pre-engineered steel building systems. The total value of the order exceeds Rs 300 crore, involving approximately 30,000 metric tonnes (MT) of material. The project is scheduled to be completed within 12 months, with 25% of the contract value to be paid as an advance along with the order. The scope of the project includes complete design, engineering, manufacturing, supply, and erection. The company has also clarified that neither the promoter, promoter group, nor any group companies have any interest in the awarding entity. The official announcement was made on Wednesday, 02 April 2025, after market hours. Interarch Building Products is a leading provider of pre-engineered steel building solutions in India. The company possesses integrated capabilities encompassing design and engineering, manufacturing, and on-site project management for the installation and erection of pre-engineered steel structures. The company's standalone net profit surged 28.2% to Rs 28.20 in Q3 FY25 as against Rs 21.99 crore posted in Q3 FY24. Revenue from operations jumped 15% YoY to Rs 363.62 crore in the quarter ended 31 December 2024. Powered by Capital Market - Live

Coal dispatches soar around 33% on year in FY25

Ministry of Coal has announced new records in captive and commercial coal production and dispatch for the financial year 2024-25. Total coal production surged to 190.95 million tonnes (MT) as of March 31, 2025, marking a remarkable 29.79% growth over the previous year’s 147.11 MT. Coal dispatches also witnessed an extraordinary rise, reaching 190.42 MT, a 33.36% increase from the 142.79 MT recorded in FY 2023-24. Captive mines achieved 24.72% growth in production and 27.76% in dispatch from the previous year, ensuring a steady supply to core industries. Commercial mines also saw 67.32% surge in production and a staggering 76.71% rise in dispatch from the previous yearPowered by Capital Market - Live

Pharma stocks surge as Trump's 26% tariff on India exempts sector

The Nifty Pharma Index surged 3.74% to 21,737.35, as investors reacted positively to the exemption. A White House fact sheet confirmed that pharmaceuticals would not be subjected to the new reciprocal tariffs, fueling optimism in the sector. This move comes as a relief to Indian drug manufacturers, many of which export heavily to the US. Leading the rally, Gland Pharma surged 6.65%, followed by Natco Pharma at 5.31% and Lupin, which gained 4.79%. Other major gainers included Aurobindo Pharma (+4.7%), Sun Pharmaceutical Industries (+4.44%), and Ipca Laboratories (+4.28%). Several other pharma giants also saw strong gains, including Divi's Laboratories (+3.59%), Dr. Reddy's Laboratories (+3.04%), Zydus Lifesciences (+2.98%), Cipla (+2.63%), Granules India (+2.54%), Biocon (+2.22%), Alkem Laboratories (+1.91%), Torrent Pharmaceuticals (+1.86%), Laurus Labs (+1.79%), Ajanta Pharma (+1.73%), Glenmark Pharmaceuticals (+1.67%), Abbott India (+1.39%), JB Chemicals & Pharmaceuticals (+0.69%), and Mankind Pharma (+0.22%). The United States is India's biggest market for pharmaceutical exports, making the exemption a significant relief for Indian drug manufacturers. However, this does not guarantee that pharmaceutical imports will remain tariff-free indefinitely. The White House's 2 April agenda did not include industry-specific tariffs, but the media reports suggest that levies on pharma goods could still be introduced at a later stage. The media reports indicate that drugmakers are actively lobbying President Trump to implement any potential tariffs gradually, allowing them time to adjust their manufacturing strategies. Powered by Capital Market - Live

Healthcare shares gain

Among the components of the BSE Healthcare index, Gland Pharma Ltd (up 7.41%), Suven Life Sciences Ltd (up 6.27%),Jubilant Pharmova Ltd (up 6.12%),Strides Pharma Science Ltd (up 6.03%),Neuland Laboratories Ltd (up 5.58%), were the top gainers. Among the other gainers were Suven Pharmaceuticals Ltd (up 5.32%), Gufic BioSciences Ltd (up 5.17%), Lupin Ltd (up 5.01%), Wockhardt Ltd (up 5%), and Syncom Formulations (India) Ltd (up 4.97%). On the other hand, Astrazeneca Pharma India Ltd (down 2.64%), Thyrocare Technologies Ltd (down 1.56%), and Krishna Institute of Medical Sciences Ltd (down 1.21%) moved lower.At 09:47 IST, the BSE SmallCap was up 117.61 or 0.25% at 47253.76.The BSE 150 MidCap Index index was down 51.84 points or 0.36% at 14416.74.The Nifty 50 index was down 87.55 points or 0.38% at 23244.8.The BSE Sensex index was down 378.24 points or 0.49% at 76239.2.On BSE,1967 shares were trading in green, 1141 were trading in red and 137 were unchanged.Powered by Capital Market - Live

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Lagging behind the market in financials growth

Average profitability - not good, not bad

The creamy layer - amongst the top performing stocks

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Aditya BSL Gold ETF objective is to generate returns that are in line with the performance of gold, subject to tracking errors

Aditya BSL Gold ETF

Average daily traded value of the ETF is high

Aditya BSL Gold ETF

Aditya BSL Gold ETF

BSLGOLDETF Share Price

Aditya BSL Gold ETF Related News & Opinions